Sanofi News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

06.07.16	Sanofi Pasteur Signs Research Agreement for Zika Vaccine (GlobeNewswire)
06.07.16	Medivation Reaches Confidentiality Agreements, Incl. With Sanofi (RTTNews)
05.07.16	Sanofi Enters into Confidentiality Agreement with Medivation and Will be Provided Due Diligence Access and Confidential Information (GlobeNewswire)
05.07.16	Regeneron Says Japan Approves Praluent To Treat Hypercholesterolemia (RTTNews)
05.07.16	Sanofi and Regeneron Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in Japan (GlobeNewswire)
27.06.16	Sanofi and Boehringer Ingelheim have reached definitive agreements to swap Sanofi's Animal Health and Boehringer Ingelheim's Consumer Healthcare businesses (GlobeNewswire)
14.06.16	Sanofi Announces Expiration of Hart-Scott-Rodino Waiting Period Regarding Proposed Acquisition of Medivation (GlobeNewswire)
13.06.16	Sanofi Files Consent Solicitation To Remove And Replace Medivation's Board (RTTNews)
13.06.16	Sanofi Files Definitive Consent Solicitation to Remove and Replace Medivation's Board (GlobeNewswire)
13.06.16	Sanofi : LixiLan Diabetes Drug Trials Meet Primary Endpoints (RTTNews)
12.06.16	Sanofi Announces Positive Phase 3 Results for Investigational Titratable Fixed-Ratio Combination of Insulin Glargine and Lixisenatide (GlobeNewswire)
09.06.16	Sanofi Launches Action 2016, a Worldwide Employee Stock Purchase Plan (GlobeNewswire)
08.06.16	Sanofi Files Investor Presentation Regarding Proposed Acquisition of Medivation (GlobeNewswire)
06.06.16	Regeneron: Dupilumab With Topical Corticosteroids Superior To Treatment With TCS (RTTNews)
06.06.16	Sanofi and Regeneron Announce that Dupilumab Used with Topical Corticosteroids (TCS) was Superior to Treatment with TCS Alone in Long-term Phase 3 Trial in Inadequately Controlled Moderate-to-Sever... (GlobeNewswire)
01.06.16	Sanofi Requests Record Date for Consent Solicitation to Remove and Replace Medivation's Board of Directors (GlobeNewswire)
26.05.16	No Pain, Only Gain For INNL, FDA Panel Backs SNY, Wait Continues For SRPT (RTTNews)
26.05.16	FDA Panel Recommends Approval Of Sanofi Treatment For Adults With Type2 Diabetes (RTTNews)
26.05.16	Sanofi: FDA Advisory Committee Recommends Approval of Sanofi Treatment for Adults with Type 2 Diabetes (GlobeNewswire)
25.05.16	Medivation Urges Stockholders To Reject Sanofi's Consent Solicitation (RTTNews)
25.05.16	Sanofi Files Consent Solicitation To Remove and Replace Medivation's Board (GlobeNewswire)
23.05.16	Sanofi Reports Changes To Its Executive Committee - Quick Facts (RTTNews)
23.05.16	Sanofi Announces Changes to Executive Committee Aligned to its Strategic Roadmap 2020 (GlobeNewswire)
13.05.16	Sanofi Files For HSR Notification On Proposed Acquisition Of Medivation (RTTNews)
12.05.16	Sanofi Files for Hart-Scott-Rodino Notification Regarding Proposed Acquisition of Medivation (GlobeNewswire)
05.05.16	Sanofi Ready To Raise Medivation Bid, Threatens To Go Hostile Bid (RTTNews)
05.05.16	Sanofi Sends Letter to Medivation's Board of Directors (GlobeNewswire)
04.05.16	Sanofi: Annual General Shareholder Meeting of May 4, 2016 (GlobeNewswire)
01.05.16	Biotech Stocks Facing FDA Decision In May (RTTNews)
29.04.16	Sanofi Comments on Medivation's Rejection of Proposal (GlobeNewswire)
29.04.16	Sanofi Q1 Net Profit Up, But Sales Down; Backs 2016 Earnings View; Stock Dips (RTTNews)
29.04.16	Sanofi Q1 Profit Rises, Net Sales Down; Backs FY16 EPS View - Quick Facts (RTTNews)
28.04.16	Medivation Receives Non-binding Proposal From Sanofi - Quick Facts (RTTNews)
28.04.16	Sanofi Offers To Buy Medivation For About $9.3 Bln In Cash (RTTNews)
28.04.16	Sanofi : Sanofi Offers to Acquire Medivation for $52.50 Per Share in Cash (GlobeNewswire)
08.04.16	Sanofi: Availability of the Pre-quarterly Results Communication (GlobeNewswire)
05.04.16	MannKind Says Regains Afrezza Marketing Rights From Sanofi (RTTNews)
01.04.16	Regeneron: Two Dupilumab Phase 3 Studies Meets Primary Endpoints - Quick Facts (RTTNews)
29.03.16	Sanofi successfully prices EUR 1.8 billion bond issue (GlobeNewswire)
29.03.16	Sanofi Names Yong-Jun Liu Head Of Research, Global R&D, Effective April 1 (RTTNews)
29.03.16	Sanofi Appoints Dr. Yong-Jun Liu as Head of Research (GlobeNewswire)
24.03.16	Odyssey Hits The Mark, SPHS Awaits Data In Q2, TEVA Breathes Easy (RTTNews)
23.03.16	Regeneron, Sanofi: Praluent Study Meets Goal In LDL Apheresis Therapy Patients (RTTNews)
23.03.16	Sanofi and Regeneron Announce Positive Topline Results from Phase 3 Praluent® (alirocumab) Study in Patients Undergoing LDL Apheresis Therapy (GlobeNewswire)
16.03.16	Sanofi and Regeneron Strongly Disagree with U.S. Jury Verdict in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection and Will Appeal (GlobeNewswire)
16.03.16	Sanofi, DiCE Molecules To Collaborate To Discover Potential Therapeutics (RTTNews)
16.03.16	Sanofi and DiCE Molecules Announce Research Collaboration to Discover Potential Therapeutics Based on Unique Small Molecule Discovery Platform (GlobeNewswire)
11.03.16	Regeneron: Sarilumab Shows Stronger Efficacy Than Adalimumab In Phase 3 Study (RTTNews)
11.03.16	Sanofi and Regeneron Announce Topline Results of Phase 3 Monotherapy Study Demonstrating Superiority of Sarilumab vs. Adalimumab in Patients with Active Rheumatoid Arthritis (GlobeNewswire)
10.03.16	Sanofi Appoints Dr. Ameet Nathwani to Executive Committee and Executive Vice President, Group Chief Medical Officer (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

18:01		Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus
18:01		Starker Wochentag in New York: S&P 500 zeigt sich am Mittag fester
18:01		NASDAQ 100 aktuell: NASDAQ 100 am Mittag mit grünem Vorzeichen
17:58		Zuversicht in London: FTSE 100 beendet die Freitagssitzung in der Gewinnzone
17:58		Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen
17:58		Handel in Frankfurt: TecDAX letztendlich in Grün
17:58		Freundlicher Handel: Börsianer lassen SPI schlussendlich steigen

18:01

Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus

18:01

Starker Wochentag in New York: S&P 500 zeigt sich am Mittag fester

18:01

NASDAQ 100 aktuell: NASDAQ 100 am Mittag mit grünem Vorzeichen

17:58

Zuversicht in London: FTSE 100 beendet die Freitagssitzung in der Gewinnzone

17:58

Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen

17:58

Handel in Frankfurt: TecDAX letztendlich in Grün